Research Article

The Use of Complementary and Integrative Health Approaches in Patients with Behcet Disease and Its Relationship with Quality of Life

Volume: 9 Number: 1 January 1, 2023
TR EN

The Use of Complementary and Integrative Health Approaches in Patients with Behcet Disease and Its Relationship with Quality of Life

Abstract

Aim: This study aims to determine the effect of common symptoms on Quality of Life (QoL) in patients with Behcet Disease (BD) and complementary and integrative health approaches used by patients to cope with these symptoms. Methods: The population of this descriptive study consisted of all patients with BD (n = 330) who are registered with the Behçet’s Disease and Familial Mediterranean Fever Patients Association. The data were collected by the researcher and the president of the association, via an online form between 31.08.2020-06.12.2020. The sample consisted of all patients with BD who met the inclusion criteria (n=247). The data were collected using the Patient Information Form, BD Current Activity Form (BDCAF) and Behçet's Disease Quality of Life Scale (BDQoL). Findings: Joint involvement, rectal bleeding, eye involvement, number of attacks, and disease activity are determinants of 42.5% in affecting QoL (R2 = 0.425, p <0.001). 37.5% of patients with BD have been using CIHA for the last 1 year. They use black mulberry molasses (32%), coriander (9.3%), and thyme juice mouthwash (4%) for mouth sores, wet cupping (24%), and St. John’s wort oil (19%) for genital wounds among CIHA methods. Conclusion: The decisive factor in the use of CIHA in patients with BD was to have genital wounds or loss of sensation in the arm. Therefore, the results of this study are important in terms of leading to further experimental studies to determine the CIHA to be used for symptoms in patients with BD.

Keywords

References

  1. 1. Bernabe E, Marcenes W, Mather J, Philips C, Fortune F. Impact of Behçet’s syndrome on health-related quality of life: influence of the type and number of symptoms. Rheumatology 2010;49(11):2165-2171.
  2. 2. Ideguchi H, Akiko S, Mitsuhiro T, Atsuhisa U, Shigeru O, Yoshiaki I. Behçet disease: evolution of clinical manifestations. Medicine 2011;90(2):125-132.
  3. 3. Ryu HJ, Seo MR, Choi HJ, Beak HJ. Clinical phenotypes of Korean patients with Behcet disease according to gender, age at onset, and HLA-B51. The Korean Journal of Internal Medicine 2018;33(5):1025-1031.
  4. 4. Greco A, De Virgilio A, Ralli M, Ciofalo A, Mancini P, Attanasio G, De Vincentiis M, Lambiase A. Behçet's disease: New insights into pathophysiology, clinical features and treatment options. Autoimmunity Reviews 2018;17(6):567-575.
  5. 5. Disease CfDoBs. International study group for Behcet's disease. Lancet 1990;335(8697):1078-1080.
  6. 6. Yurdakul S, I Günaydin, Y Tüzün, N Tankurt, H Pazarli, Y Ozyazgan, H Yazici. The prevalence of Behcet's syndrome in a rural area in northern Turkey. The Journal of Rheumatology 1988;15(5):820.
  7. 7. Azizlerli G, Akdağ Köse A, Sarıca R, Gül A, Tutkun IT, Kulaç M, Tun. R, Urgancioğlu M, Dişçi R. Prevalence of Behçet's disease in Istanbul, Turkey. International Journal of Dermatology 2003;42(10):803-806.
  8. 8. Canpolat Ö, Yurtsever S. The quality of life in patients with Behçet’s disease. Asian Nursing Research 2011;5(4):229-235.

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Research Article

Publication Date

January 1, 2023

Submission Date

September 9, 2021

Acceptance Date

February 26, 2022

Published in Issue

Year 2023 Volume: 9 Number: 1

Vancouver
1.Zeynep Erdoğan, Mehmet Ali Kurçer, Ufuk Demirel. The Use of Complementary and Integrative Health Approaches in Patients with Behcet Disease and Its Relationship with Quality of Life. Akd Med J. 2023 Jan. 1;9(1):51-9. doi:10.53394/akd.993166